Abbott has issued a warning regarding the sensors on some of its blood sugar monitoring systems, stating that they may need to be replaced to prevent inaccurate readings. The company revealed that testing showed certain sensors on the FreeStyle Libre 3 system could incorrectly report high blood sugar levels, potentially leading patients to take insulin when it is not necessary.
The affected devices were distributed in the United States during the first half of May. Abbott estimates that less than 1% of U.S. users are impacted by this issue. However, customers residing outside the U.S. or using different versions of the FreeStyle Libre system are not affected by this sensor replacement.
